A major new European research collaboration will target haematological cancers, it has been announced.
Three major European cancer charities have teamed up to support projects targeted at cancers of the blood, liver, prostate, and bowel.
The charities, based in the UK, Italy and Spain, will be supporting six international projects with a total of £30 million, they said.
Cancer Research UK is working with the Associazione Italiana per la Ricerca sul Cancro and Asociación Española Contra el Cáncer on the project.
One of the projects, led by researchers at the Clinica Universidad de Navarra, Spain, will investigate drug resistance in incurable haematological malignancies, with the hope of identifying new treatment opportunities.
Meanwhile, CAR-T therapy is to be studied at the University of Milan-Bicocca, Italy, and a Newcastle-based team will invstigate immunotherapy in liver cancer. The other projects are seeking a blood test for advanced prostate cancer, tracking cancer cell evolution, and finding new routes for personalising treatment in bowel cancer.
Dr Iain Foulkes, from Cancer Research UK, said: “No single organisation or country is going to beat cancer on its own.
“Research must be prioritised as the UK builds a new relationship with the EU, as much-needed breakthroughs in treatment are dependent on collective action from the international research community.”
Isabel Orbe, from the Spanish charity AECC, said: “A global collaboration is needed to accelerate results in cancer research. This charity partnership will provide tools to support researchers in an international framework, helping them to create multidisciplinary networks and support the research of new unexplored areas.”
Source: Cancer Research UK: https://www.cancerresearchuk.org/about-us/cancer-news/press-release/2018-09-20-european-cancer-research-gets-ps30-million-vote-of-confidence
Disclaimer: The news stories shared on this site are used as a way to inform our members and followers of updates and relevant information happening in Haematology. The BSH does not endorse the content of news items from external sources, and is not in a position to verify the findings, accuracy or the source of any studies mentioned. Any medical or drugs information is provided as an information resource only, and is not to be relied on for any diagnostic or treatment purposes.
News service provided by Englemed News http://www.englemed.co.uk/